Results 131 to 140 of about 8,636 (217)

Dutch participatory surveillance framework for evaluating evolutionary changes on SARS-CoV-2 affecting rapid diagnostic test sensitivity in 2022 - 2023. [PDF]

BMC Infect Dis
Kozanli E, Han W, Smit T, de Bakker J, Elahi M, Jaarsma R, Carstens G, van Hoek AJ, Eggink D.   +8 more
europepmc   +1 more source

Electro-deposition of Copper on a Filter Template for Growing Nanowires

This lesson, presented by the National Nanotechnology Coordinated Infrastructure, allows students a chance to experiment using the electro-plating process to produce nanowires.

core  

A New Paradigm: 46 Structural Cell Types Function as Environment‐Supporting Innate Immune Cells, With Endothelial and Vascular Smooth Muscle Cells as Key Prototypes

iNew Medicine, EarlyView.
ABSTRACT The scope, organization, and biological significance of innate immune functions across structural cell types remain poorly defined. To address these fundamental knowledge gaps, we analyzed experimental data of transcriptomes generated by our group and others.
Juanjuan Liu, Gayani K. Nanayakkara, Yifan Lu, Fatma Saaoud, Keman Xu, Ying Shao, Bo Yuan, Shih‐Yu Hung, Haiyan Xiang, Xianwei Wang, Sadia Mohsin, Sheng Wu, Xiaolei Liu, Juncheng Wei, Zhengjie Zhou, Beata Kosmider, Mingui Fu, Laisel Martinez, Roberto Vazquez‐Padron, Wenhui Hu, Shuping Ge, Hong Wang, Xiaofeng Yang   +22 more
wiley   +1 more source

Childhood Interstitial Lung Disease (chILD) Associated With Toxic Chemical Inhalation Exposures: A State-of-the-Art Review. [PDF]

Pediatr Pulmonol
Hadley W, Lacagnina R, Rahman I, Casey AMH, Deterding R, Deutsch G, McGraw MD.   +6 more
europepmc   +1 more source

Nerandomilast and the Evolving Therapeutic Paradigm in Pulmonary Fibrosis: From Mechanism to Clinical Efficacy

iNew Medicine, EarlyView.
Therapeutic mechanism, clinical efficacy and future directions for nerandomilast in pulmonary fibrosis. ABSTRACT The recent Phase III FIBRONEER trials establish nerandomilast, a novel oral phosphodiesterase 4B (PDE4B) inhibitor, as an effective therapy for idiopathic and progressive pulmonary fibrosis. By elevating cyclic adenosine monophosphate (cAMP),
Qianwen Bai, Jia Deng, Hongquan Wang, Yao Yao, Tao Wang   +4 more
wiley   +1 more source

Genetic algorithm-based coverage path planning for autonomous aircraft cabin cleaning by reconfigurable robot. [PDF]

PLoS One
Dinh CH, Qi CY, Van HV, Chen G, Mohan RE, Le AV.   +5 more
europepmc   +1 more source

Tiny carriers, big impact: How Fusobacterium nucleatum extracellular vesicles drive oral diseases and beyond

Interdisciplinary Medicine, EarlyView.
This review explores how Fusobacterium nucleatum extracellular vesicles drive local oral diseases and distal pathologies via sophisticated cross‐compartment cross talk. It highlights the transformative potential of these “tiny carriers” as next‐generation molecular intermediaries for advanced health monitoring and innovative bio‐interventions by ...
Rongyang Ma, Jiahui Huang, Yitong Chen, Haoxuan Wang, Hang Zou, Wanghong Zhao, Zilong Deng   +6 more
wiley   +1 more source

Molecular insights into mRNA export regulation by the human TREX-2 complex. [PDF]

Nat Commun
Gong X, Tao R, Ge X, Zhu H, Li M, Chen Y, Gao Y, Hang J, Zhang X.   +8 more
europepmc   +1 more source

A counterfactual and random intercept cross‐lagged panel analysis of the effects of reading frequency on adolescent mental health in a large longitudinal study

JCPP Advances, EarlyView.
Abstract Background Reading has been proposed as a protective factor in mental health; however, evaluating this is challenging due to a lack of trials and the possibility of confounding in observational studies. Methods We used the complementary approaches of covariate balancing propensity score weighting and random intercepts cross‐lagged panel models
Aja Murray, Patrick Errington, Yi Yang, Helen Wright, Daniel Mirman, Ingrid Obsuth, Tom Booth, Denis Ribeaud, Manuel Eisner   +8 more
wiley   +1 more source

Association between team functioning and self-efficacy and quality of life for primary care patients in British Columbia, Nova Scotia, and Ontario. [PDF]

Prim Health Care Res Dev
Ndateba I, Havaei F, Haase KR, Hogg W, Martin-Misener R, Wong ST.   +5 more
europepmc   +1 more source